aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed May 14, 2019 · 10-Q · 44 days after period end · 0001564590-19-019133
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$6.14M | -$10.67M | -$13.41M | -$16.09M |
| EPS Diluted | -$2.54 | -$5.01 | -$0.56 | -$0.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end
